Abstract
1696P - Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have